We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc (TDOC) Suffers a Larger Drop Than the General Market: Key Insights
Read MoreHide Full Article
Teladoc (TDOC - Free Report) closed at $5.42 in the latest trading session, marking a -3.39% move from the prior day. This move lagged the S&P 500's daily loss of 1.36%. At the same time, the Dow lost 1.64%, and the tech-heavy Nasdaq lost 1.46%.
Shares of the telehealth services provider witnessed a gain of 23.03% over the previous month, beating the performance of the Medical sector with its loss of 5.66%, and the S&P 500's loss of 1.76%.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of -$0.3, marking a 57.89% fall compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $612.3 million, down 2.71% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of -$0.86 per share and a revenue of $2.51 billion, demonstrating changes of +24.56% and -0.81%, respectively, from the preceding year.
Any recent changes to analyst estimates for Teladoc should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.93% higher. Teladoc presently features a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 86, placing it within the top 36% of over 250 industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Teladoc (TDOC) Suffers a Larger Drop Than the General Market: Key Insights
Teladoc (TDOC - Free Report) closed at $5.42 in the latest trading session, marking a -3.39% move from the prior day. This move lagged the S&P 500's daily loss of 1.36%. At the same time, the Dow lost 1.64%, and the tech-heavy Nasdaq lost 1.46%.
Shares of the telehealth services provider witnessed a gain of 23.03% over the previous month, beating the performance of the Medical sector with its loss of 5.66%, and the S&P 500's loss of 1.76%.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of -$0.3, marking a 57.89% fall compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $612.3 million, down 2.71% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of -$0.86 per share and a revenue of $2.51 billion, demonstrating changes of +24.56% and -0.81%, respectively, from the preceding year.
Any recent changes to analyst estimates for Teladoc should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.93% higher. Teladoc presently features a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 86, placing it within the top 36% of over 250 industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.